Literature DB >> 503376

Eisenmenger's syndrome and pregnancy.

N Gleicher, J Midwall, D Hochberger, H Jaffin.   

Abstract

Two additional cases of successfully managed Eisenmenger's syndrome (ES) during pregnancy are described. A review of the literature on this subject revealed 115 reported cases, of which only 44 (including our two cases) were felt to be adequately documented, representing 70 pregnancies. These formed the material for statistical evaluation. Fifty-two per cent of all patients died in connection with pregnancy. Thirty and three-tenths per cent of all pregnancies results in maternal death. Maternal mortality in first, second, and third pregnancies was not significantly different. A high incidence of maternal death was assoicated with hypovolemia, thromboembolic phenomena and preeclampsia, but mortality was not higher in the toxemia than in the non-toxemia group. Cesarean sections and other operations are associated with extremely high maternal mortality during pregnancy. Thirty-four per cent of all vaginal deliveries, three out of four cesarean sections, and only 1 out of 14 pregnancy interruptions (the only one by hysterotomy) resulted in maternal death. Abortions are significantly safer than any kind of delivery (p less than 0.05). Ventricular septal defect (VSD) is the most frequent underlying shunt defect. Maternal mortality in association with VSD is higher (60%) than in association with atrial septal defect (ASD) (44%) and patent ductus arteriosus (PDA) (41.7%). The majority of maternal deaths occurred during or within the first week after delivery. Only 25.6 per cent of all pregnancies reached term. At least 54.9 per cent of all deliveries occurred prematurely. Thirty and two-tenths per cent of all infants showed intrauterine growth retardation. This represented almost half of all new borns with available information. Perinatal mortality reached 28.3 per cent and was significantly associated with prematurity (p less than 0.001). Pregnancy is contraindicated in patients with ES. Abortion is the treatment of choice, once pregnancy has occurred. Where interruption of pregnancy is refused, utmost care must be taken to assure maternal and fetal survival. A protocol for the management of such pregnancies is discussed on the basis of available information.

Entities:  

Mesh:

Year:  1979        PMID: 503376     DOI: 10.1097/00006254-197910000-00001

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  29 in total

Review 1.  Heart disease and pregnancy.

Authors:  S C Siu; J M Colman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 2.  [The heart during pregnancy].

Authors:  Michael E Hall; Eric M George; Joey P Granger
Journal:  Rev Esp Cardiol       Date:  2011-10-01       Impact factor: 4.753

Review 3.  Epidural anaesthesia for labour and caesarean section in a parturient with a single ventricle and transposition of the great arteries.

Authors:  J Fong; M Druzin; A A Gimbel; J Fisher
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

4.  Successful outcome of eisenmenger with term pregnancy.

Authors:  Somajita Chakraborty; Sucheta Mukherjee; Arnab Datta; Subir Banerjee
Journal:  J Obstet Gynaecol India       Date:  2013-02-05

5.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

6.  Pregnancy and congenital heart disease.

Authors:  C M Oakley
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

7.  Successful pregnancy outcome with eisenmenger syndrome.

Authors:  Partha Mukhopadhyav; Popli Bhattacharya; Nilofur Begum
Journal:  J Obstet Gynaecol India       Date:  2012-01-24

8.  Pregnancy in patients with heart disease: experience with 1,000 cases.

Authors:  Walkiria Samuel Avila; Eduardo Giusti Rossi; José Antonio Franchini Ramires; Max Grinberg; Maria Rita Lemos Bortolotto; Marcelo Zugaib; Protasio Lemos da Luz
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

9.  Alfentanil for urgent caesarean section in a patient with severe mitral stenosis and pulmonary hypertension.

Authors:  M A Batson; S Longmire; E Csontos
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

10.  Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.

Authors:  Chrisen H Maharaj; Daniel O'Toole; Tadhg Lynch; John Carney; James Jarman; Brendan D Higgins; John J Morrison; John G Laffey
Journal:  Reprod Biol Endocrinol       Date:  2009-04-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.